Here are relevant reports on : healthcare-documentation-workflow-automation-market
-
Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) - Global Forecast to 2020
The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.
- Published: February 2016
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Global Forecast to 2031
The global next-generation sequencing market is projected to reach USD 27.14 billion by 2031, growing at a CAGR of 14.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Biobanking Market by Product (Equipment, Consumables, Software), Services (Virtual), Operation (Automated), Workflow (Storage, Collection, Transport), Sample (Blood, Cell Lines, Nucleic Acids), Application, Ownership, End User - Global Forecast to 2030
The global biobanking market, valued at US$7.16 billion in 2024, stood at US$7.65 billion in 2025 and is projected to advance at a resilient CAGR of 9.1% from 2025 to 2030, culminating in a forecasted valuation of US$11.82 billion by the end of the period. Several factors contribute to the growth of the biobanking market, including growing focus on precision or personalized medicine, continuously expanding cell & gene therapy pipeline, and end-to-end automation for sample handling & storage.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031
The global proteomics market is projected to reach USD 67.55 billion by 2031, growing at a CAGR of 11.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cloud Enterprise Content Management Market by Solution (Document Management, Case Management, Workflow Management, Record Management, and E-Discovery), Service, Deployment Model, Organization Size, Vertical, and Region - Global Forecast to 2022
The cloud Enterprise Content Management (ECM) market size is expected to grow from USD 9.77 Billion in 2017 to USD 34.42 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 28.6%. The major drivers of this market include the growth in the digital content across enterprises, easier access from remote end-points, need for protection of enterprise data against the disaster, and need for regulatory compliances.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.5billion by the end of the period. NGS platforms have undergone continuous technological innovations over the last several years.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2030
The Asia Pacific Next-generation Sequencing market, valued at US$3.11 billion in 2024, stood at US$3.40 billion in 2025 and is projected to advance at a resilient CAGR of 16.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.38 billion by the end of the period. Market growth is supported by substantial public and private investment in genomics, including national genome and precision medicine initiatives in China, Japan, India, South Korea, Singapore, and Australia, alongside ongoing advances that are lowering sequencing costs and improving throughput and data analytics.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Europe Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030
The Europe Next-generation Sequencing Market, valued at US$4.11 billion in 2024, stood at US$4.42 billion in 2025 and is projected to advance at a resilient CAGR of 15.0% from 2025 to 2030, culminating in a forecasted valuation of US$8.88 billion by the end of the period. The Europe next-generation sequencing market is expanding on the back of accelerating use of sequencing across oncology, rare disease diagnostics, and broader precision medicine programs, supported by robust public and private research funding
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
South Korea Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing (Consumables), Platforms, Bioinformatics), Application (Drug Discovery, Diagnostic, Agriculture) - Forecast to 2031
The South Korea next-generation sequencing market, valued at USD 0.19 billion in 2025, stood at USD 0.20 billion in 2026 and is projected to advance at a resilient CAGR of 14.0% from 2026 to 2031, culminating in a forecasted valuation of USD 0.39 billion by the end of the period. The report profiles key players such as Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Netherlands), PacBio (US), and Oxford Nanopore Technologies plc. (UK).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
AI Code Assistants Market by Offering (Generative AI Code Assistants, Developer Platforms, Coding APIs, Workflow Tools), Model Type (General-Purpose, Code-Specialized, Enterprise-Tuned Generative AI Models) - Global Forecast to 2032
The AI Code Assistants market size is projected to grow from USD 8.14 billion in 2025 to USD 127.05 billion by 2032, at a CAGR of 48.1% during the forecast period. The major players in the AI code assistants market include IBM (US), Oracle (US), Microsoft (US), AWS (US), Google (US), Jetbrains (Netherlands), Replit (US), Synk (US), OpenAI (US), Anthropic (US), Datadog (US), Tabnine (Israel), Sourcegraph (US), Cursor (US), Zencoder (US), Salesforce (US), Supermaven (US), Cline (US), Sourcery AI (UK), Refact.ai (UK), AskCodi (Brazil), Augment Code (US), TabbyML (US), Qodo (Israel), and WindSurf (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
